Inventor
WU QILONG
CN31 patents
⚠️ This page may combine multiple inventors who share the name “WU QILONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
21 patentsUS10174095B2Jan 8, 2019
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
NOVARTIS AG41 citations96
US9777061B2Oct 3, 2017
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG85 citations96
US11084880B2Aug 10, 2021
Anti-BCMA chimeric antigen receptor
NOVARTIS AG15 citations93
US10287354B2May 14, 2019
Regulatable chimeric antigen receptor
NOVARTIS AG29 citations92
US10640569B2May 5, 2020
Human mesothelin chimeric antigen receptors and uses thereof
NOVARTIS AG15 citations83
US10654914B2May 19, 2020
Polyomavirus neutralizing antibodies
NOVARTIS AG5 citations82
US10577417B2Mar 3, 2020
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
NOVARTIS AG10 citations82
US10450366B2Oct 22, 2019
Polyomavirus neutralizing antibodies
NOVARTIS AG5 citations82
US10435460B2Oct 8, 2019
Polyomavirus neutralizing antibodies
NOVARTIS AG5 citations82
US11639378B2May 2, 2023
Polyomavirus neutralizing antibodies
NOVARTIS AG1 citations71
US11161894B2Nov 2, 2021
Polyomavirus neutralizing antibodies
NOVARTIS AG2 citations71
US10568947B2Feb 25, 2020
Treatment of cancer using a CLL-1 chimeric antigen receptor
NOVARTIS AG6 citations71
US11591404B2Feb 28, 2023
Treatment of cancer using a CD123 chimeric antigen receptor
NOVARTIS AG0 citations62
US10703819B2Jul 7, 2020
Treatment of cancer using a CD123 chimeric antigen receptor
NOVARTIS AG1 citations62
US12338287B2Jun 24, 2025
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG0 citations61
US12077571B2Sep 3, 2024
Polyomavirus neutralizing antibodies
NOVARTIS AG0 citations61
US11578130B2Feb 14, 2023
Regulatable chimeric antigen receptor
NOVARTIS AG1 citations61
US11459390B2Oct 4, 2022
Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor
NOVARTIS AG0 citations61
US10851166B2Dec 1, 2020
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG1 citations61
US11999794B2Jun 4, 2024
Human mesothelin chimeric antigen receptors and uses thereof
NOVARTIS AG0 citations60
US11981731B2May 14, 2024
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
NOVARTIS AG0 citations60
XIAMEN CHANGELIGHT CO LTD
4 patentsUS11621375B2Apr 4, 2023
Light-emitting diode chip and method of manufacturing the same
XIAMEN CHANGELIGHT CO LTD4 citations66
US11456399B2Sep 27, 2022
Light emitting diode (LED) chip and manufacturing method and light emitting method thereof
XIAMEN CHANGELIGHT CO LTD1 citations59
US10468550B2Nov 5, 2019
Light-emiting diode device and method of producing the same
XIAMEN CHANGELIGHT CO LTD0 citations49
US11621380B2Apr 4, 2023
Flip-chip of light emitting diode and manufacturing method and illuminating method thereof
XIAMEN CHANGELIGHT CO LTD0 citations48